drugset / Trial / NCT00326235

Effects of Buspirone in Opiate Withdrawal

NCT00326235

RandomizedParallel-groupDouble-blindTreatment

Summary

Dependence on heroin is a major public health problem because of its association with criminality, law enforcement costs and healthcare costs. Managed withdrawal is a required first step for a long term drug-free treatment of heroin addicts. Methadone and clonidine have been the mainstay of treatment for the relief of heroin withdrawal symptoms but both have limitations. The purpose of this study was to evaluate the efficacy of buspirone in the alleviation of the withdrawal symptoms experienced by heroin addicts when they stop using heroin. Buspirone is a non opiate drug with no abuse potential, no sedating effects and no withdrawal symptoms.

Timeline

Start
2002-01
Primary completion
Completion
2004-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Buspirone Small molecule 30 mg
Subject Buspirone Small molecule 45 mg

Indications